Home/Filings/4/0001209191-23-005067
4//SEC Filing

BERNSTEIN HOWARD PHD MD 4

Accession 0001209191-23-005067

CIK 0001604477other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 4:40 PM ET

Size

5.3 KB

Accession

0001209191-23-005067

Insider Transaction Report

Form 4
Period: 2023-01-24
BERNSTEIN HOWARD PHD MD
Chief Scientific Officer
Transactions
  • Award

    Stock Option

    2023-01-24+830,000830,000 total
    Exercise: $0.73Exp: 2033-01-24Common Stock (830,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying securities on January 24, 2024 and in 36 substantially equal monthly installments thereafter, subject to limited acceleration upon involuntary termination.

Issuer

SQZ Biotechnologies Co

CIK 0001604477

Entity typeother

Related Parties

1
  • filerCIK 0001262409

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:40 PM ET
Size
5.3 KB